Bajaj HealthCare Limited

BAJAJHCARE.NS·NSE·Healthcare
Compare
325.10−13.40 (−3.96%)today
As of Oct 21, 1:34 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close338.50
Open335.00
Day range323.00343.60
52-week range272.35488.90
Off day high−5.38%
Off 52-week high−33.50%
Volume125.53K
Avg. volume (3M)177.04K
Market cap10.94B
EPS (TTM)7.31
Forward P/E—
P/E ratio (TTM)44.47
Dividend yield0.44% (1.50)
Beta (5Y)0.29
Shares outstanding33.67M
Short interest—
Earnings dateAug 12, 2025 (est.)
Analyst target—
Profit margin2.81%

Against its peers

Compare in full ›
BAJAJHCARE.NS AARTIDRUGS.BO RDY GRANULES.BO SYNCOMF.BO KERALAYUR.BO
Market cap 10.94B 35.35B 11.05B 195.54B 20.75B 1.83B
P/E (TTM) 44.5 18.5 30.1 35.8 23.5 —
Forward P/E — 13.9 20.3 26.9 — —
Price/book 2.1 2.3 16.4 4.9 5.0 16.9
Dividend yield 0.44% 0.50% 0.63% 0.26% 0.47% —
1-year change −25.89% −22.50% −10.83% +0.63% +29.98% −65.50%
Today −3.96% −2.94% +1.38% −0.10% +3.04% −3.79%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

LiveLawBiz·Positive

NCLT Mumbai Allows Bajaj Healthcare To Acquire GENRX Pharmaceuticals

17 Oct 2026 3:00 PM IST The National Company Law Tribunal's Mumbai Bench has allowed Bajaj Healthcare Limited to acquire GENRX Pharmaceuticals Private Limited as a going concern on a 'clean slate' basis, protecting it from past liabilities…

scanx.trade·Positive

Bajaj Healthcare secures NCLT approval for Genrx acquisition

Bajaj Healthcare Limited received approval from the National Company Law Tribunal (NCLT) Mumbai Bench for the acquisition of Genrx Pharmaceuticals Private Limited on a going concern basis. The order was passed on October 13, 2026, and…

From articles in the 4Search news index.

In the news

5mentions in 30 days
5with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.